Category Archives: Eczema

Mike Garten Advertisement - Continue Reading Below When Steven Q. Wang, M.D., one of the country's leading dermatologists, created a special calming ointment for his patients, the last thing he expected was to share it with millions of TV viewers. But that's exactly what happened late last year, when he appeared on HSN's American Dreams. He was an instant hit and all units of Dr. Wang's Eczema Ointment Natural Calming Moisturizer completely sold out! Of course, we weren't surprised. For years, Dr. Wang has been one of the GH Beauty Lab's go-to medical experts for everything skin-related. Plus, 30 million Americans suffer from eczema, and over 100 million struggle with sensitive skin. Dr. Wang developed the balm after reading about how Chinese herbs help ease skin disorders. Curious about whether Eastern medicine could help his patients, he asked his father, Gui Wang, LAc, an herbalist and a licensed acupuncturist, for insight. Three years later, they developed the formula of traditional Chinese herbs and skin-soothing ingredients. "The blend is key. We don't believe there's one single thing that will solve the problem," Dr. Wang says. To try it: Use a small amount, and rub in well. The vibrant color is a … Continue reading →

Dyshidrotic eczema is characterized by the development of blisters on the palms of hands or soles of feet. They can also appear on fingers and toes. The blisters are itchy and typically last for a few weeks. They may be caused by seasonal allergies, stress and making contact with certain types of metals such as nickel. The good news is that dyshidrotic eczema is manageable and is not contagious. Symptoms Eczema generally causes redness and itching, regardless of what type it is. Symptoms of dyshidrosis include blisters, itching, flaking, redness, cracked skin, discomfort and pain. Understanding the eczema you have, symptoms and triggers makes it easier to manage and treat it. Controlling and Preventing Outbreaks Diagnosis A careful skin examination will enable your doctor to diagnose the condition. Since the symptoms may be similar to other skin conditions that affect skin, further tests such as skin biopsies may be recommended. Allergy testing may also be considered if dyshidrotic eczema is linked to allergies. Treatment Solutions There are different ways to treat dyshidrosis and these are usually determined by how severe the outbreak is as well as other pertinent factors. You may need to try different treatments before identifying the best … Continue reading →

Sanofi and Regeneron have taken a deeper dive into phase 3 data on hotly tipped atopic dermatitis drug dupilumab. The fresh results further burnish the credentials of an asset that is up for review at FDA this month. Dupilumab, which will be sold under the brand name Dupixent if it wins approval, has aced a series of tests over the past year. The latest analysis, which looks at one of three phase 3 studies of the IL-4 and IL-13 inhibiting antibody, continues the winning streak. Dupilumab comfortably beat the placebo against a range of secondary endpoints, regardless of whether the analysis was run after 16 or 52 weeks of treatment. Having revealed in June that the CHRONOS trial met its primary endpoint of skin lesion clearances after 16 weeks and cleared some key secondary goals, Sanofi and Regeneron have followed up with data on other measurements. The trial linked both dupilumab regimenswhich gavethe experimental drug with topical corticosteroidsto statistically significant improvements on the Pruritus Numerical Rating Scale, Patient Oriented Eczema Measure and Dermatology Life Quality Index at 16 and 52 weeks. The proportion of patients whose condition improved against these scales at 16 and 52 weeks were comparable, adding to … Continue reading →

Infectious Disease Advisor (registration) Intramuscular Flu Vaccination Recommended for Patients With Eczema Infectious Disease Advisor (registration) Intramuscular rather than intradermal flu vaccination is preferred in patients with S aureus colonized atopic dermatitis. HealthDay News For patients with moderate/severe atopic dermatitis (AD), those colonized with Staphylococcus aureus have a ... Continue reading here: Intramuscular Flu Vaccination Recommended for Patients With Eczema - Infectious Disease Advisor (registration) … Continue reading →

Do Parental Allergic Diseases Affect Offspring Skin Sensitivity? Monthly Prescribing Reference (registration) Questionnaires about parental and infantile eczema, atopic dermatitis (AD), and other allergic diseases were administered and skin prick tests (SPTs) with saline and histamine (1.0 mg/dL) were performed on infants' arms. Resulting wheal sizes were ... Read more: Do Parental Allergic Diseases Affect Offspring Skin Sensitivity? - Monthly Prescribing Reference (registration) … Continue reading →

PARIS Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis (AD) had been positive. "In the CHRONOS study, Dupixent used with topical corticosteroids showed significantly greater clearance of skin lesions and overall disease severity compared to topical corticosteroids alone, which are commonly prescribed for moderate-to-severe atopic dermatitis," Andrew Blauvelt, the principal investigator of the study, said in a joint statement from the companies. "This study provides positive long-term data for Dupixent, which is important given atopic dermatitis is a chronic inflammatory disease," he said. A biologics license application (BLA) for Dupixent was accepted for Priority Review by the U.S. Food and Drug Administration (FDA) in September 2016. (Reporting by Matthias Blamont; writing by John Irish; Editing by Clelia Oziel) MAIQUETIA, Venezuela Venezuelan plumber Marcos Heredia scoured 20 pharmacies in one day but could not find crucial medicines to stop his epileptic 8-year-old from convulsions that caused irreparable brain damage late last year. (Reuters Health) - - Obese people in the U.S. may not receive the same kind of care at the end of their lives as people who are thin or normal weight, suggests … Continue reading →

The Indian Express Pre-pregnancy stress level may lead to eczema in future child The Indian Express A Southampton research show, infants, whose mothers felt stressed before they fell pregnant, had a higher risk of eczema the age of 12 months. The study from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, is the ... Pre-Pregnancy Stress May Lead to Eczema in InfantsNDTV all 2 news articles » The rest is here: Pre-pregnancy stress level may lead to eczema in future child - The Indian Express … Continue reading →

Nemolizumab significantly reduced the itch and improved appearance of skin WebMD News from HealthDay By Steven Reinberg HealthDay Reporter THURSDAY, March 2, 2017 (HealthDay News) -- An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds. Nemolizumab is a man-made, injectable antibody that acts against the protein that has been identified as playing a part in eczema, the international team of researchers said. "The treatments for atopic dermatitis [eczema] have been disappointing because of their lack of efficacy and the long-term side effects," said Dr. Doris Day, a dermatologist at Lenox Hill Hospital in New York City. She had no role in the study. "There are also issues with compliance, since the products often need to be applied to broad areas multiple times a day," she added. Since this is a chronic condition, continued treatment is usually needed to maintain results, Day explained. "The goal is to find a non-steroid treatment that is easy to follow, and with reliable results and minimal adverse effects," she said. While the hope is always for a cure, the results of this trial "are encouraging and give hope to those suffering from … Continue reading →

New U.K. research suggests that stress before conception can increase the risk of eczema in children. Carried out by the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, the study is the first to link maternal stress before conception with the risk of atopic eczema in future children. For the research the study assessed the stress levels of women recruited to the Southampton Women's Survey before they were pregnant. Participants were asked to report how stressed they were in their daily lives with a sub-group also asked about their psychological wellbeing. Around 3,000 babies were born to women taking part in the survey, who were then assessed for eczema at the ages of six months and 12 months. The results showed that more than one in six women reported that stress affected their health 'quite a lot' or 'extremely' before falling pregnant, with the analysis showing that the infants of these mothers had a 20 per cent higher likelihood of developing atopic eczema at age 12 months when compared with the children of other participants. The results also suggested that stress and low mood experienced closer to the time of conception may have an even greater impact on eczema … Continue reading →

A new treatment may help reduce the itch of atopic dermatitis, which will reduce flare-ups. Meredith Rizzo/NPR hide caption A new treatment may help reduce the itch of atopic dermatitis, which will reduce flare-ups. People with moderate to severe eczema may benefit from new treatments that significantly reduce the intense itching that comes with the scaly skin disease. A study published Wednesday finds that the antibody nemolizumab, given as a monthly injection, not only reduces itching significantly but also clears up many of the patches of dry, inflamed skin that are part of the disease. It appears in the New England Journal of Medicine. "At 12 weeks there was very significant improvement," says dermatologist Jon Hanifin of the Oregon Health and Science University. "Not 100 percent, but patients were delighted not to have the itching that was keeping them up at night." The study was done in 216 patients with moderate-to-severe eczema to determine the best dose of nemolizumab. They were randomized to receive either a placebo or a low, moderate or high dose of the drug, injected once a month. Those who got the low dose reported a 44 percent reduction in itching, using a scale of 1 to … Continue reading →